1Liang MH, Mahdl LA, Costenbader K, et al. Atherosclerotic vascular disease in systemic lupus erythematosus. J Natl Med Assoc, 2002,94:813-819.
2Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus: quantification olr degrees olr narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med ,1981,70 : 775-781.
3Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy.Am J Med , 1975,58:243-264.
4MacGregor AJ, Dhillon VB, Binder A, et al. Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. Ann Rheum Dis,1992,51:152-155.
5Romero FI, Atsumi T, Tinahones FJ, et al. Autoantibodies against malondialdehyde-modified lipoprotein (a) in antiphospholipid syndrome. Arthritis Rheum, 1999,42:2606-2611.
6Landewe RB, van den Borne BE, Breedveld FC, et al.Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet ,2000,355:1616-1617.
7Rahman P, Urowitz MB, Gladman DD, et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol, 1999, 26: 2363-2368.
8Ura M, Sakata R, Nakayama Y, et al. Coronary artery bypass grafting in patients with systemic lupus erythematosus. Eur J Cardiothorae Surg , 1999,15:697-701.
9Rangel A, Lavalle C, Chavez E, et al. Myocardial infarction in patients with systemic lupus erythematosus with normal findings from coronary arteriography and without coronary vasculitis case reports. Angiololgy, 1999,50:245-253.
10Morton KE, Gavaghan TP, Krilis SA, et al. Coronary artery bypass graft failure-an autoimmune phenomenon? Lancet, 1986,2:1353-1357.